Alpa Laboratories Limited
Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.
Alpa Laboratories Limited - Asset Resilience Ratio
Alpa Laboratories Limited (ALPA) has an Asset Resilience Ratio of 58.21% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Alpa Laboratories Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Alpa Laboratories Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 0% |
| Short-term Investments | ₹1.38 Billion | 58.21% |
| Total Liquid Assets | ₹1.38 Billion | 58.21% |
Asset Resilience Insights
- Very High Liquidity: Alpa Laboratories Limited maintains exceptional liquid asset reserves at 58.21% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Alpa Laboratories Limited Industry Peers by Asset Resilience Ratio
Compare Alpa Laboratories Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Alpa Laboratories Limited (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Alpa Laboratories Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 49.65% | ₹1.11 Billion | ₹2.23 Billion | -0.32pp |
| 2024-03-31 | 49.98% | ₹911.43 Million | ₹1.82 Billion | +4.28pp |
| 2023-03-31 | 45.70% | ₹765.24 Million | ₹1.67 Billion | +1.45pp |
| 2022-03-31 | 44.25% | ₹686.99 Million | ₹1.55 Billion | +15.27pp |
| 2021-03-31 | 28.99% | ₹406.90 Million | ₹1.40 Billion | -3.39pp |
| 2020-03-31 | 32.38% | ₹392.96 Million | ₹1.21 Billion | +7.67pp |
| 2019-03-31 | 24.72% | ₹299.61 Million | ₹1.21 Billion | +10.17pp |
| 2018-03-31 | 14.55% | ₹176.82 Million | ₹1.22 Billion | -20.91pp |
| 2017-03-31 | 35.46% | ₹445.10 Million | ₹1.26 Billion | +11.58pp |
| 2016-03-31 | 23.87% | ₹344.50 Million | ₹1.44 Billion | +24.36pp |
| 2015-03-31 | -0.48% | ₹-6.18 Million | ₹1.28 Billion | -0.48pp |
| 2011-03-31 | 0.00% | ₹10.00K | ₹1.29 Billion | -0.47pp |
| 2008-03-31 | 0.47% | ₹7.08 Million | ₹1.50 Billion | +0.28pp |
| 2007-03-31 | 0.19% | ₹1.16 Million | ₹605.85 Million | -0.02pp |
| 2006-03-31 | 0.21% | ₹1.11 Million | ₹531.74 Million | -0.19pp |
| 2005-03-31 | 0.39% | ₹1.12 Million | ₹285.53 Million | -0.17pp |
| 2004-03-31 | 0.57% | ₹1.43 Million | ₹251.71 Million | -0.10pp |
| 2003-03-31 | 0.67% | ₹1.42 Million | ₹213.51 Million | +0.16pp |
| 2002-03-31 | 0.51% | ₹999.00K | ₹196.92 Million | -- |